ERCP in Idiopathic Recurrent Acute Pancreatitis
NCT01583517 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89
Last updated 2014-10-10
Summary
The therapeutic impact of ERCP with sphincterotomy in the management of patients with idiopathic recurrent acute pancreatitis (RAP) needs further study. The investigators conducted a single center, feasibility, randomized trial to determine 1) the role of pancreatic manometry in predicting future episodes of RAP and 2) differences in the efficacy of no, biliary (BES) or pancreatobiliary (dual) endoscopic sphincterotomy (DES).
Conditions
- Recurrent Acute Pancreatitis
Interventions
- PROCEDURE
-
Biliary sphincterotomy
Cutting of the biliary sphincter muscle.
- PROCEDURE
-
Pancreatobiliary sphincterotomy
Cutting of both the biliary and pancreatic sphincter muscles.
- PROCEDURE
-
Sham
No sphincterotomy is performed in patients randomized to sham with normal SOM.
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Stuart Sherman, MD · Indiana University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-09-30
- Primary Completion
- 2012-04-30
- Completion
- 2014-10-31
Countries
- United States
Study Locations
More Related Trials
-
The Prophylactic Effect of Stilamin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
NCT01431781 ·Status: UNKNOWN ·Phase: NA
-
Percutaneous Lesioning Splanchnic Nerves in Patients With Chronic Pancreatitis
NCT01005017 ·Status: UNKNOWN ·Phase: NA
-
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
NCT00609726 ·Status: COMPLETED
-
Endoscopic Versus Surgical Treatment of Chronic Pancreatitis
NCT01520675 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic and Interventional Therapy in Acute Pancreatitis
NCT00699933 ·Status: UNKNOWN
-
ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?
NCT02602574 ·Status: UNKNOWN
-
The Clinical Utility of Cholangioscopy and Pancreatoscopy in the Diagnosis and Management of Pancreaticobiliary Disorders
NCT00861198 ·Status: COMPLETED
-
Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
NCT04619511 ·Status: COMPLETED
-
Preventing Recurrent 'Idiopathic' Acute Pancreatitis Through Laparoscopic Cholecystectomy (PICUS-2)
NCT06391359 ·Status: RECRUITING ·Phase: NA
-
Early Precut Versus Pancreatic Stent for Post-ERCP Pancreatitis
NCT02497872 ·Status: COMPLETED ·Phase: NA
-
Oral Resveratrol to Prevent Post-ERCP Pancreatitis
NCT02947932 ·Status: UNKNOWN ·Phase: PHASE4
-
Pancreatic Duct Stent for Acute Necrotizing Pancreatitis
NCT03115918 ·Status: COMPLETED ·Phase: NA
-
Laparoscopic Cholecystectomy in Idiopathic Pancreatitis
NCT00784355 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
NCT04770857 ·Status: UNKNOWN
-
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
NCT01438385 ·Status: UNKNOWN
-
PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
NCT05310409 ·Status: COMPLETED
-
Randomized Trial of Immediate Endoscopic Necrosectomy vs. Step-up Endoscopic Interventions in Necrotizing Pancreatitis
NCT05043415 ·Status: UNKNOWN ·Phase: NA
-
Study on Predictive Factors, Safety and Efficacy of Endoscopic Retrograde Accessory Pancreatography in CP
NCT06684301 ·Status: COMPLETED
-
Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures
NCT01580709 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Resection of Papillary Adenomas; a Novel Treatment Algorithm to Prevent Recurrence - a Pilot-study (ERASE-pilot)
NCT05339607 ·Status: UNKNOWN ·Phase: NA
-
The Development and Evaluation of a Novel Duodenoscope Assessment Tool
NCT04004533 ·Status: COMPLETED
-
Computer Aided, Non-invasive, Acoustic Gastrointestinal Surveillance in Post-ERCP Pancreatitis
NCT02433444 ·Status: UNKNOWN
-
A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis
NCT00727740 ·Status: COMPLETED ·Phase: NA
-
Diclofenac for Prevention of Post-ERC Pancreatitis
NCT03595150 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Diclofenac vs. Placebo in a Randomized Double Blind Controlled Trial in Post ERCP Pancreatitis
NCT01946984 ·Status: COMPLETED ·Phase: PHASE1